Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for LISA in Preterm Infants
NCT04820101Unknown
- Sponsor
- Università di Padova
- Start
- May 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dexmedetomidine in respiratory distress syndrome (RDS), sponsored by Università di Padova. Primary endpoints: Effectiveness of dexmedetomidine in achieving sedation for LISA procedure and Safety of dexmedetomidine in sedating preterm infants at 24 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT04820101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04820101.